<?xml version="1.0" encoding="UTF-8"?>
<p>
 <bold>3. Evaluation of Priming Effects of H5N2 pLAI Vaccine on the Subsequent Response to Inactivated H5N1 Vaccine</bold> (“OrniFlu”, Federal State Scientific-Industrial Company Microgen for Immunobiological Medicines, Ministry of Health, Russia)
 <sup>
  <xref rid="CIT0010">10</xref>
 </sup>
</p>
